Paul J Clancy's Net Worth
$56.2 Million
Estimate Recalculated Nov 11, 2024 02:43AM EST
Who is Paul J Clancy?
Paul J Clancy has an estimated net worth of $56.2 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC., INCYTE CORP, AGIOS PHARMACEUTICALS, INC., EXACT SCIENCES CORP, Xilio Therapeutics, Inc., and ALEXION PHARMACEUTICALS INC.
SEC CIK
Paul J Clancy's CIK is 0001409601
Past Insider Trading and Trends
2021 was Paul J Clancy's most active year for acquiring shares with 13 total transactions. Paul J Clancy's most active month to acquire stocks was the month of January. 2013 was Paul J Clancy's most active year for disposing of shares, totalling 39 transactions. Paul J Clancy's most active month to dispose stocks was the month of January. 2013 saw Paul J Clancy paying a total of $6,886,770.25 for 172,282 shares, this is the most they've acquired in one year. In 2013 Paul J Clancy cashed out on 292,057 shares for a total of $36,182,871.47, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN IDEC INC. (BIIB) Snapshot price: $200.5
Executive VP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -47.78% | -9.89K |
$290.00 | -$2,868,680.00 | 10.81K |
Scheduled
|
Apr 25
| ||
Form 4
| -32.33% | -9.89K |
$291.55 | -$2,883,721.05 | 20.7K |
Scheduled
|
Mar 13
| ||
Form 4
| +13.87% | 3.73K |
$279.35 | -$853,134.81 | 30.6K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
| +1.15% | 306 |
$258.99 | -$70,704.27 | 26.87K |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +8.85% | 2.16K |
$247.22 | -$420,026.78 | 26.56K |
Feb 12
| |||
Form 4
| +9.65% | 2.15K |
$250.77 | -$262,556.19 | 24.4K |
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| +11.37% | 2.27K |
$392.11 | -$794,414.86 | 22.26K |
Feb 12
| |||
Form 4
| +29.30% | 4.53K |
$398.63 | -$1,336,590.80 | 19.98K |
Feb 8 - Feb 9
| |||
Form 4
| +17.15% | 2.26K |
$347.11 | -$700,467.98 | 15.46K |
Feb 23
| |||
Form 4
| +12.66% | 1.48K |
$323.04 | -$427,704.96 | 13.19K |
Feb 12
| |||
Form 4
| +65.23% | 4.62K |
$315.54 | -$1,028,344.86 | 11.71K |
Feb 8 - Feb 9
| |||
Form 4
|
—
|
0
|
$147.32 | -$5,232,449.75 | 7.09K |
Scheduled
|
Sep 18
| ||
Form 4
|
—
|
0
|
$147.19 | -$18,039,416.01 | 7.09K |
Scheduled
|
Sep 16
| ||
Form 4
| -76.91% | -23.61K |
$222.75 | -$5,259,505.88 | 7.09K |
Scheduled
|
Apr 29 - Apr 30
| ||
Form 4
| +7.95% | 2.26K |
$164.40 | -$332,252.40 | 30.7K |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
| +20.44% | 4.83K |
$164.44 | -$432,477.20 | 28.44K |
Feb 8 - Feb 9
| |||
Form 4
| -1.22% | -291.00 |
$116.51 | -$532,688.74 | 23.61K |
Feb 23 - Feb 24
| |||
Form 4
| +12.92% | 2.73K |
$117.78 | -$230,495.46 | 23.9K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
$86.48 | -$1,434,912.00 | 21.17K |
Scheduled
|
Feb 1
| ||
Form 4
| -48.88% | -20.24K |
$112.35 | -$2,274,401.22 | 21.17K |
Scheduled
|
Jan 3
| ||
Form 4
| -1.98% | -835.00 |
$102.90 | -$85,921.50 | 41.41K |
Aug 1
| |||
Form 4
| -10.49% | -4.95K |
$70.05 | -$1,341,968.65 | 42.25K |
Scheduled
|
Apr 28
| ||
Form 4
| +6.46% | 2.86K |
$65.07 | -$145,968.70 | 47.2K |
Mar 5
| |||
Form 4
| -4.65% | -2.16K |
$67.26 | -$145,550.64 | 44.34K |
Feb 24
| |||
Form 4
| +5.45% | 2.4K |
$66.76 | -$74,704.44 | 46.5K |
Feb 23
| |||
Form 4
| -3.68% | -1.69K |
$65.83 | -$110,989.38 | 44.1K |
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
| -2.38% | -1.11K |
$56.24 | -$62,651.36 | 45.78K |
Sep 4
| |||
Form 4
| -1.75% | -835.00 |
$55.88 | -$46,659.80 | 46.9K |
Aug 1
| |||
Form 4
| -2.56% | -1.25K |
$47.22 | -$59,166.66 | 47.73K |
Jun 1
| |||
Form 4
| +19.08% | 7.85K |
$55.29 | -$117,325.38 | 48.98K |
Feb 23 - Feb 24
| |||
Form 4
| -5.63% | -2.45K |
$55.21 | -$135,485.34 | 41.14K |
Feb 12
| |||
Form 4
| -2.49% | -1.11K |
$51.01 | -$56,825.14 | 43.59K |
Sep 4
| |||
Form 4
| -2.58% | -1.18K |
$47.55 | -$56,251.65 | 44.7K |
Aug 1
| |||
Form 4
| -2.66% | -1.25K |
$50.90 | -$63,777.70 | 45.89K |
Jun 1
| |||
Form 4
| +27.16% | 10.07K |
—
|
—
| 47.14K |
Feb 24
| |||
Form 4
| -6.35% | -2.40K |
$52.61 | -$126,369.22 | 35.41K |
Feb 12
| |||
Form 4
| -1.32% | -529.00 |
$52.48 | -$27,761.92 | 39.47K |
Feb 6
| |||
Form 4
| -3.74% | -1.55K |
$50.00 | -$77,650.00 | 40K |
Scheduled
|
Sep 19
| ||
Form 4
| -2.61% | -1.11K |
$48.16 | -$53,650.24 | 41.55K |
Sep 4
| |||
Form 4
| -1.31% | -568.00 |
$50.66 | -$28,776.88 | 42.67K |
Scheduled
|
Aug 8
| ||
Form 4
| +15.29% | 5.74K |
$50.01 | -$13,252.65 | 43.24K |
Aug 1
| |||
Form 4
| -10.09% | -4.21K |
$56.01 | -$235,679.14 | 37.5K |
Scheduled
|
Jul 1
| ||
Form 4
| -2.23% | -953.00 |
$62.75 | -$59,800.75 | 41.71K |
Jun 1
| |||
Form 4
| -4.87% | -2.18K |
$60.22 | -$131,460.60 | 42.66K |
Scheduled
|
Feb 21
| ||
Form 4
| -2.22% | -1.02K |
$62.20 | -$63,257.40 | 44.85K |
Feb 17
| |||
Form 4/A
| +43.89% | 13.99K |
$60.78 | -$103,332.08 | 45.86K |
Scheduled
|
Feb 12
| ||
Form 4
| +15.01% | 13.99K |
$60.76 | -$103,332.08 | 107.17K |
Scheduled
|
Feb 12
| ||
Form 4
| -1.61% | -522.00 |
$60.52 | -$31,591.44 | 31.87K |
Feb 6
| |||
Form 4
| +32.79% | 8K |
—
|
—
| 32.4K |
Sep 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INCYTE CORP (INCY) Snapshot price: $60.96
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.14% | 399 |
$60.62 | $24,187.38 | 19.01K |
Jun 28
| |||
Form 4
| +17.93% | 2.83K |
—
|
—
| 18.61K |
Jun 12
| |||
Form 4
| +2.62% | 403 |
$56.97 | $22,958.91 | 15.79K |
Mar 28
| |||
Form 4
| +2.75% | 412 |
$62.79 | $25,869.48 | 15.38K |
Dec 29
| |||
Form 4
| +2.60% | 379 |
$57.77 | $21,894.83 | 14.97K |
Sep 29
| |||
Form 4
| +2.67% | 380 |
$62.25 | $23,655.00 | 14.59K |
Jun 30
| |||
Form 4
| +21.40% | 2.5K |
—
|
—
| 14.21K |
Jun 14
| |||
Form 4
| +2.79% | 318 |
$72.27 | $22,981.86 | 11.71K |
Mar 31
| |||
Form 4
| +2.65% | 294 |
$80.32 | $23,614.08 | 11.39K |
Scheduled
|
Dec 30
| ||
Form 4
| +3.15% | 339 |
$66.64 | $22,590.96 | 11.09K |
Scheduled
|
Sep 30
| ||
Form 4
| +3.08% | 321 |
$75.97 | $24,386.37 | 10.76K |
Scheduled
|
Jun 30
| ||
Form 4
| +25.86% | 2.14K |
—
|
—
| 10.43K |
Jun 15
| |||
Form 4
| +4.09% | 326 |
$79.42 | $25,890.92 | 8.29K |
Scheduled
|
Mar 31
| ||
Form 4
| +4.50% | 343 |
$73.40 | $25,176.20 | 7.96K |
Scheduled
|
Dec 31
| ||
Form 4
| +4.40% | 321 |
$68.78 | $22,078.38 | 7.62K |
Scheduled
|
Sep 30
| ||
Form 4
| +4.03% | 283 |
$84.13 | $23,808.79 | 7.3K |
Scheduled
|
Jun 30
| ||
Form 4
| +37.75% | 1.92K |
—
|
—
| 7.02K |
May 26
| |||
Form 4
| +6.21% | 298 |
$81.27 | $24,218.46 | 5.09K |
Scheduled
|
Mar 31
| ||
Form 4
| +6.22% | 281 |
$86.98 | $24,441.38 | 4.8K |
Scheduled
|
Dec 31
| ||
Form 4
| +6.11% | 260 |
$89.74 | $23,332.40 | 4.51K |
Scheduled
|
Sep 30
| ||
Form 4
| +5.69% | 229 |
$103.97 | $23,809.13 | 4.25K |
Scheduled
|
Jun 30
| ||
Form 4
| +46.72% | 1.28K |
—
|
—
| 4.03K |
May 26
| |||
Form 4
| +11.68% | 287 |
$73.23 | $21,017.01 | 2.74K |
Scheduled
|
Mar 31
| ||
Form 4
| +10.38% | 231 |
$87.32 | $20,170.92 | 2.46K |
Scheduled
|
Dec 31
| ||
Form 4
| +13.57% | 266 |
$74.23 | $19,745.18 | 2.23K |
Scheduled
|
Sep 30
| ||
Form 4
| +13.76% | 237 |
$84.96 | $20,135.52 | 1.96K |
Scheduled
|
Jun 28
| ||
Form 4
| +748.77% | 1.52K |
—
|
—
| 1.72K |
Apr 26
| |||
Form 4
|
∞
| 203 |
$86.01 | $17,460.03 | 203 |
Scheduled
|
Mar 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
| No matching records found | |||||||||
AGIOS PHARMACEUTICALS, INC. (AGIO) Snapshot price: $43.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +31.93% | 1.58K |
—
|
—
| 6.55K |
May 20
| |||
Form 4
| +51.43% | 1.69K |
—
|
—
| 4.96K |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| +134.14% | 1.88K |
—
|
—
| 3.28K |
May 28 - May 29
| |||
Form 4
|
∞
| 1.4K |
—
|
—
| 1.4K |
May 29 - May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EXACT SCIENCES CORP (EXAS) Snapshot price: $59.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +37.03% | 5.44K |
—
|
—
| 20.14K |
Jun 13
| |||
Form 4
| +32.42% | 3.6K |
—
|
—
| 14.7K |
Jun 8
| |||
Form 4
| +102.00% | 5.61K |
—
|
—
| 11.1K |
Jun 9
| |||
Form 4
| +87.64% | 2.57K |
—
|
—
| 5.5K |
Jun 30
| |||
Form 4
|
∞
| 2.93K |
—
|
—
| 2.93K |
Mar 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||